Z-0233-2015 Class III Terminated

Recalled by Biomerieux — Letoile, N/A

FDA device recall Z-0233-2015 was initiated by Biomerieux on Oct 16, 2014 and is designated Class III. Reason for recall: The products have a wrong expiration date on their labeling, 5 years instead of 2 years. The recall status is terminated (terminated Nov 30, 2017). Affected quantity: 652 devices.

Recall details

Product Type
Devices
Report Date
Nov 26, 2014
Initiation Date
Oct 16, 2014
Termination Date
Nov 30, 2017
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
652 devices

Product description

Etest¿ Ceftaroline (CPT32) US B100. Etest¿ (Antimicrobial Susceptibility Testing) is a quantitative technique for determining the antimicrobial susceptibility of Gram negative and Gram positive aerobic bacteria.

Reason for recall

The products have a wrong expiration date on their labeling, 5 years instead of 2 years.

Distribution pattern

Worldwide Distribution-US (nationwide) including DC and the states of AL, AK, AR, AZ, CA, CO, DE, FL, GA, IA, IN, KY, MA, MD, MI, MO, NC, NE, NY, OH, OK, PA, SC, TN, TX, UT, VA, WA, WI, and the countries of Australia, Austria, China, Czech Republic, France, Germany, India, Italy, Japan, Netherlands, Poland, Portugal, Switzerland, Sweden, Turkey, United Kingdom, Egypt, Pakistan, Slovenia and Uruguay.

Code information

Ref #537548, Lot #1003202820, Right Expiry date: 27-APR-2016

Source

Dataset
openFDA device recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for Z-0233-2015
openFDA file date
Nov 16, 2026
Loaded by RegDataLab
Nov 17, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for Z-0233-2015. Report a data issue: hello@regdatalab.com.